Perception, Cognition, and Gait in Parkinson's Disease

Parkinson Disease Clinical Trial

Official title:

Perception, Cognition, and Gait in Parkinson's Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03241966
• Other study ID #: 1204E
• Status: Completed
• Start date: April 1, 2017
• Est. completion date: January 15, 2019

Study information

• Verified date: February 2021
• Source: Boston University Charles River Campus
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators are examining how aspects of daily function are perceived in persons with PD and in those who interact with them on a regular basis. If eligible, participants will receive a set of online questionnaires by email. The questionnaires will take about 1 hour to complete, and can be done at the participant's convenience. The investigators are looking for volunteers who have a diagnosis of Parkinson's disease without dementia (age 40 or older and proficient English speakers). If a spouse, family member, significant other or other close associate is available (age 18 or older, proficient English speakers), the investigators will send them questionnaires as well. There is no monetary or other compensation for this study. For more information, please contact the Vision and Cognition Laboratory at vcognition@gmail.com or 617-358-1377.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 439
• Est. completion date: January 15, 2019
• Est. primary completion date: January 15, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years to 100 Years

Eligibility

Inclusion Criteria:

• Diagnosed with Parkinson's disease without dementia OR close associate of someone with Parkinson's disease

• 40 years or older

• Proficient English speaker

• Access to a computer

• 8+ years of education

Exclusion Criteria:

• Co-existing active neoplasm, serious cardiac disease, other serious chronic medical illness

• Prior intracranial surgery

• History of traumatic brain injury

• Psychiatric or neurological diagnoses other than Parkinson's disease

• History of alcoholism or other drug abuse

• History of treatment with electroshock therapy

Related Conditions & MeSH terms

• Parkinson Disease

Locations

Country	Name	City	State
United States	Vision and Cognition Laboratory at Boston University	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Boston University Charles River Campus

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Parkinson's Disease Questionnaire (PDQ-39)	Measures the health status of Parkinson's disease patients and the impact the disease has on their aspects of daily living. There are 39 items.	Within 24 hours of starting the study